Mergers and Acquisitions

Health law sign-ups start, and some see a 'hostile takeover'

It's sign-up season for the Affordable Care Act, but the Trump administration isn't making it easy — cutting the enrollment period in half, slashing advertising and dialing back on counselors who help consumers get through the process.

Health law sign-ups start, and some see a 'hostile takeover'

It's sign-up season for the Affordable Care Act, but the Trump administration isn't making it easy — cutting the enrollment period in half, slashing advertising and dialing back on counselors who help consumers get through the process.

Strayer Education, Capella to merge in $1.9B deal

Iran is fulfilling its commitments under the nuclear deal with world powers and U.N. inspectors are facing no problems in their verification efforts, the International Atomic Energy Agency (IAEA) director-general said on Monday.

Strayer Education, Capella to merge in $1.9B deal

Iran is fulfilling its commitments under the nuclear deal with world powers and U.N. inspectors are facing no problems in their verification efforts, the International Atomic Energy Agency (IAEA) director-general said on Monday.

Lennar to buy CalAtlantic Group in about $9.3b deal

Lennar said on Monday it would buy smaller rival CalAtlantic Group in a stock-and-cash deal valued at about $9.3 billion, including debt, to create the largest homebuilder in the United States.

Lennar to buy CalAtlantic Group in about $9.3b deal

Lennar said on Monday it would buy smaller rival CalAtlantic Group in a stock-and-cash deal valued at about $9.3 billion, including debt, to create the largest homebuilder in the United States.

Novartis to buy France's Advanced Accelerator for $3.9b

Swiss drugmaker Novartis on Monday offered to buy France's Advanced Accelerator Applications in a $3.9 billion cash deal to strengthen the oncology portfolio at the world's biggest maker of prescription medicines.

Novartis to buy France's Advanced Accelerator for $3.9b

Swiss drugmaker Novartis on Monday offered to buy France's Advanced Accelerator Applications in a $3.9 billion cash deal to strengthen the oncology portfolio at the world's biggest maker of prescription medicines.